GSK716155 subcutaneous injections

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 2

Phase 1

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

CompletedNCT00394030

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2006-10-16End: 2007-03-20Updated: 2017-09-11

Phase 2

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

CompletedNCT00354536

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2006-02-28End: 2006-09-30Updated: 2016-10-26

Related Papers

Clinical pharmacology of albiglutide, a GLP-1 receptor agonist.

2014-11-0128 citations